Cansativa

Overview
Cansativa is a German wholesaler, importer, processor and distributor of medical cannabis, operated by Cansativa GmbH. It is based in Moerfelden-Walldorf in Hessen and was founded in 2017 by Jakob and Benedikt Sons with their father. It supplies pharmacies and pharmaceutical wholesalers rather than patients directly, and in 2020 was contracted by the Federal Republic of Germany to handle distribution for the cannabis agency at the Federal Institute for Drugs and Medical Devices, BfArM.

Why this entity matters
Cansativa is the clearest DACH example of a startup whose entire market was created by a change in statute, and of the operating consequences that follow. It built pharmaceutical-grade logistics rather than a consumer brand, which is what made it eligible for a federal distribution mandate. That mandate makes it a structurally significant node: for a period it was the single channel through which domestically cultivated medical cannabis reached German pharmacies.

Company history and product
Cansativa began wholesale operations in May 2018 in Frankfurt-Fechenheim and moved in 2019 to Moerfelden-Walldorf, where it built warehousing and a clean-room facility for the final processing and bottling of cannabis flower. Since 2022 it has run its own brands, AMICI and N!CE, and from 2023 it has exported into other European markets.

In 2020 the Federal Republic of Germany awarded Cansativa the contract for storage, logistics and distribution of cannabis cultivated in Germany under the BfArM cannabis agency. Trade reporting put the mandate at 10,400 kilograms over four years and described Cansativa as the sole distributor of German-grown medical cannabis. In February 2022 it raised a USD 15 million Series B led by the United States cannabis venture firm Casa Verde Capital, with Argonautic Ventures and the German family investment firm Alluti participating. The company reported net sales above EUR 17 million for 2023 and, in later trade interviews, revenue above EUR 65 million for 2025 and a German market share above 28 percent, all company-reported.

Role in the DACH startup and technology ecosystem
Cansativa sits where German pharmaceutical distribution meets a statutory framework that changed twice in seven years. Germany's medical-cannabis framework took effect in spring 2017, enabling prescription and reimbursement by statutory health insurers, and the BfArM cannabis agency was created to oversee domestic cultivation. With effect from 1 April 2024 the Cannabis Act, CanG, moved medical cannabis into a dedicated statute, the MedCanG, and replaced the earlier tender allocation for domestic cultivation with a licensing procedure administered by the agency. Those are matters of public record.

Selected relationships and affiliations
Leadership: Benedikt Sons, chief executive, and Jakob Sons, both registered managing directors of Cansativa GmbH. Public sector: the BfArM cannabis agency, as contracting authority for the distribution mandate. Investors: Casa Verde Capital as lead of the 2022 Series B, with Argonautic Ventures and Alluti. Commercial: its own AMICI and N!CE brands plus distribution partnerships with international brands. Related Startuprad.io entities: https://www.startuprad.io/entities/sanity-group and https://www.startuprad.io/entities/hessen-trade-and-invest .

Startuprad.io relevance
Cansativa is the regulated-market reference entity in the Startuprad.io graph and an anchor for Rhine-Main coverage. Five posts carry the Cansativa tag: a founder interview on Germany's approval of cannabis for medical use, a 2023 news roundup and three Rhine-Main funding analyses.

Public source context
Sources used: the company's own history at https://www.cansativa.de/en/cansativa/about-us/ ; trade reporting on the 2020 BfArM mandate from MJBizDaily, New Cannabis Ventures, Apotheke Adhoc and Handelsblatt; the BfArM cannabis agency's published material on cultivation under the MedCanG; and reporting on the 2022 Series B from MJBizDaily, TechCrunch and PR Newswire. Revenue and market-share figures are company-reported.

Startuprad.io coverage of Cansativa

Cansativa appears in the following Startuprad.io interviews, analysis and long-form profiles.

Startup News Germany — Summer 2023 (July/ August) | Startupradio Episode #393
Published: 15 March 2026
Last updated: 30 August 2026
Coverage type: News
https://www.startuprad.io/post/this-month-in-german-swiss-and-austrian-gsa-startups-summer-2023-july-august-startupradio

Startups in Greater Frankfurt/Rhine-Main-Area Raised in H1 2022 more Funding Than in All of 2021
Published: 15 March 2026
Last updated: 29 August 2026
Coverage type: Analysis
https://www.startuprad.io/post/startups-in-greater-frankfurt-rhine-main-area-raised-in-h1-2022-more-funding-than-in-all-of-2021

Germany has approved Cannabis For Medical Use, and Legalization for Recreation Is Next — Founder Interview
Published: 15 March 2026
Last updated: 14 August 2026
Coverage type: Interview
https://www.startuprad.io/post/germany-has-approved-cannabis-for-medical-use-and-legalization-for-recreation-is-next-founder-int

Startups in Greater Rhine-Main/Frankfurt raised almost half a billion US$ in Funding
Published: 29 June 2020
Last updated: 29 August 2026
Coverage type: Analysis
https://www.startuprad.io/post/startups-in-greater-rhine-main-frankfurt-raised-almost-half-a-billion-us-in-funding

2019 Startup Financing Greater Rhine-Main Q1 2019 (85,25 M €)
Published: 16 April 2019
Last updated: 29 August 2026
Coverage type: Analysis
https://www.startuprad.io/post/2019-startup-financing-greater-rhine-main-q1-2019-85-25-m

About this record. This is the public Level 1 layer of Startuprad.io's entity intelligence architecture. Startuprad.io's deeper entity intelligence may include extended profiles, verified relationships, source trails, historical development, monitoring, news signals, custom entity sets, and analytical relationship mapping. These deeper layers are available through Startuprad.io's research, intelligence, and enterprise services.

Need deeper entity intelligence? Startuprad.io provides extended profiles, monitored entity sets, relationship analysis, source-backed research, and custom intelligence services for companies, investors, and institutions. → https://www.startuprad.io/become-a-partner

About Startuprad.io
Startuprad.io is a European B2B media, data and intelligence platform. It provides structured entity and ecosystem data, source-backed research, datasets and AI/training-data solutions, as well as strategic visibility and access to a professional European audience of founders, investors, executives and B2B decision-makers.

Organizations use Startuprad.io for intelligence and research, structured data and AI applications, executive and company positioning, and trusted B2B reach across Europe.

Canonical record: https://www.startuprad.io/entities/cansativa